Alzheimer disease: open trials in Finland

4 open trials have a site in Finland. Registry data; only the trial team decides who can take part.

NCT06976203
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Suomen Terveystalo Oy, Helsinki · CRST Helsinki Oy, Helsinki · University Of Eastern Finland, Kuopio · Suomen Terveystalo Oy, Oulu · Clinical Research Services Turku -CRST Oy, Turku
Registry updated 2026-10-08
NCT05326750
Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases
Trial Treatment · Kuopio University Hospital
Kuopio University Hospital, Kuopio
Registry updated 2026-10-02
NCT07502560
A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland
Trial Treatment · Phase 4 · GlaxoSmithKline
Espoo · Helsinki · Jarvenpaa · Kokkola · Oulu · Seinäjoki · Tampere · Turku
Registry updated 2026-05-12
NCT07105709
Open-label Extension Study in Participants With Early Alzheimer's Disease
Trial Treatment · Phase 2 · GlaxoSmithKline
Oulu
Registry updated 2026-02-02

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)